BUP One Step Buprenorphine Rapid Test (Urine)
Rapid lateral flow immunoassay for the qualitative detection of buprenorphine in urine, used by healthcare professionals to monitor opioid substitution therapy. CE Marked.
Product Description
This competitive lateral flow immunoassay detects buprenorphine in urine. Colloidal gold particles coated with anti-buprenorphine antibody are contained in the conjugate pad, and immobilized buprenorphine conjugate is fixed at the test line. Urine migrating by capillary action brings any drug into contact with the labelled antibody; buprenorphine competes with the conjugate for the limited binding sites. When the drug occupies those sites, antibody particles cannot be captured at the test line and the test line disappears. A negative sample leaves the sites free and a colored test line forms. A control line confirms adequate sample and proper wicking.
Buprenorphine is a potent opioid analgesic used for pain relief and as substitution treatment for opioid dependence, sometimes combined with naloxone. Urine levels after therapeutic dosing are generally low, whereas higher concentrations may indicate misuse, so testing can support compliance monitoring. The assay yields only a qualitative, preliminary result and cannot measure the parent drug or its metabolite. Other opioids may cross-react, and a negative result does not exclude recent use. Confirmation by gas or liquid chromatography/mass spectrometry is recommended, with findings interpreted by a physician alongside clinical information.
Specifications
| Product Name | Cat. No. | Specimen | Cut-off | Format |
|---|---|---|---|---|
| BUP Buprenorphine | FBU03-S3 | Urine | 10ng/ml | Strip |
| BUP Buprenorphine | FBU03-C3 | Urine | 10ng/ml | Cassette |
Send an Inquiry
Tell us the product and quantity you need. We will reply by email with pricing, packaging and availability for the BUP One Step Buprenorphine Rapid Test (Urine).